Skip to main content
OpenTrials
Completed

NCT Number: NCT07356193

Serum CPK and Creatinine Changes During Plyometric Training in Collegiate Athletes

This retrospective study evaluated the effects of an eight-week lower body plyometric training program on serum creatine phosphokinase (CPK) and creatinine levels in male collegiate volleyball players. Sixty two players were divided into experimental and control groups. CPK and creatinine were measured at baseline and multiple time points during training. The study assessed whether plyometric training produced harmful biochemical changes or signs of rhabdomyolysis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–20 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Batterjee Medical College

Jeddah, Saudi Arabia

About this study

This study evaluated the physiological effects and safety of an eight-week lower body plyometric training program in male collegiate volleyball players, focusing on changes in serum creatine phosphokinase (CPK) and creatinine levels. Sixty two healthy athletes were randomly assigned to either a plyometric training group or a control group. The experimental group performed progressive lower body plyometric exercises twice weekly for eight weeks, while the control group continued regular volleyball training.

Serum CPK and creatinine were assessed at baseline and multiple time points throughout the intervention. CPK levels in the training group increased significantly early in the program, peaking on Day 4 and remaining elevated until Week 2, before returning to baseline by Week 8. Importantly, all values remained within normal clinical ranges, and no signs of rhabdomyolysis or overtraining were observed. Serum creatinine levels showed no significant changes, indicating preserved renal function. No biomarker changes were detected in the control group.

These findings indicate that an eight-week, progressively designed plyometric training program is safe and well tolerated in male collegiate volleyball players.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • male collegiate volleyball players
  • Age: 18-20 years
  • No prior plyometric training

Exclusion criteria

  • History of kidney disease
  • Current musculoskeletal injury
  • neuromuscular impairments

Treatment and study plan

Lower Body Plyometric Training

Behavioral

Training twice weekly for eight weeks, including low-, moderate-, and high-intensity plyometric exercises (squat jumps, box jumps, tuck jumps, split squat jumps, lateral hurdle jumps, zigzag jumps, single-leg tuck jumps, and depth jumps).

Control Group

Other

Routine volleyball training only; no plyometric exercises.

Primary outcomes

  1. Serum Creatine Phosphokinase (CPK) Levels

    Time frame: Baseline; Day 2; Day 4; Week 1; Week 2; Week 4; Week 6; Week 8

    Change in serum CPK measured using the CK-NAC optimized IFCC method.

Secondary outcomes

  1. Serum Creatinine Levels

    Time frame: Baseline; Day 2; Day 4; Week 1; Week 2; Week 4; Week 6; Week 8

    Measured using modified Jaffe's method.

Sponsors and collaborators

Lead sponsor

Batterjee Medical College

Other

Registry information

Official study title

Effects of Lower Body Plyometric Training on Serum Creatine Phosphokinase and Creatinine Levels in Male Collegiate Volleyball Players

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jan 21, 2026
Registry last updated
Jan 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.